Table 2 Maternal outcomes in Caesarean section
Tranexamic Group (n = 115) | Misoprostol Group (n = 115) | Control Group (n = 115) | P-value | |
|---|---|---|---|---|
Number of soaked towels | 5 (2–10) | 4 (2–9) | 6 (2–10) | < 0.001* |
Blood loss in suction apparatus (ml) | 247.4 ± 115.6 | 248.7 ± 93.5 | 395.2 ± 142.2 | < 0.001* |
Post-operative Hb (gm/dl) | 10.39 ± 0.87 | 10.58 ± 1.03 | 9.89 ± 1.07 | < 0.001* |
Hb difference (gm/dl) | -0.78 ± 0.57 | -0.83 ± 0.52 | -1.32 ± 0.57 | < 0.001* |
Post-operative HCT (%) | 31.15 ± 2.62 | 31.88 ± 3.38 | 29.76 ± 3.07 | < 0.001* |
HCT difference (%) | -3.05 ± 1.28 | -3.06 ± 1.13 | -4.94 ± 1.82 | < 0.001* |
Estimated blood loss (ml) | 641.6 ± 271.9 | 617.9 ± 207.4 | 1002.4 ± 340.7 | < 0.001* |
Incidence of postpartum haemorrhage in 1st 24 h | 2 (1.74%) | 1 (0.87%) | 3 (2.61%) | 0.601 |
Side effects | 1 (0.9%) | 0 (0.0%) | 0 (0.0%) | 0.367 |